{"id":"https://openalex.org/W2052220933","doi":"https://doi.org/10.1089/aid.1994.10.1713","title":"Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans","display_name":"Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans","publication_year":1994,"publication_date":"1994-12-01","ids":{"openalex":"https://openalex.org/W2052220933","doi":"https://doi.org/10.1089/aid.1994.10.1713","mag":"2052220933","pmid":"https://pubmed.ncbi.nlm.nih.gov/7888231"},"language":"en","primary_location":{"id":"doi:10.1089/aid.1994.10.1713","doi":"https://doi.org/10.1089/aid.1994.10.1713","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.1994.10.1713","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052220933"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111954121","display_name":"Michael C. Keefer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]},{"id":"https://openalex.org/I5388228","display_name":"University of Rochester","ror":"https://ror.org/022kthw22","country_code":"US","type":"education","lineage":["https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael C. Keefer","raw_affiliation_strings":["Department of Medicine, University of Rochester, School of Medicine and Dentistry, New York 14642"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Rochester, School of Medicine and Dentistry, New York 14642","institution_ids":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021608465","display_name":"Barney S. Graham","orcid":"https://orcid.org/0000-0001-8112-0853","observed_orcids":["https://orcid.org/0000-0001-8112-0853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barney S. Graham","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036112915","display_name":"Robert B. Belshe","orcid":"https://orcid.org/0000-0003-0940-7213","observed_orcids":["https://orcid.org/0000-0003-0940-7213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert B. Belshe","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080875085","display_name":"David H. Schwartz","orcid":"https://orcid.org/0009-0009-0419-1573","observed_orcids":["https://orcid.org/0009-0009-0419-1573"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Schwartz","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061167455","display_name":"Lawrence Corey","orcid":"https://orcid.org/0000-0002-2179-2436","observed_orcids":["https://orcid.org/0000-0002-2179-2436"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Corey","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110366547","display_name":"Dani P. Bolognesi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dani P. Bolognesi","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110494051","display_name":"Donald M. Stablein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donald M. Stablein","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004036928","display_name":"David C. Montefiori","orcid":"https://orcid.org/0000-0003-0856-6319","observed_orcids":["https://orcid.org/0000-0003-0856-6319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David C. Montefiori","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084520588","display_name":"M. Juliana McElrath","orcid":"https://orcid.org/0000-0003-2276-7117","observed_orcids":["https://orcid.org/0000-0003-2276-7117"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Juliana McELRATH","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079779458","display_name":"M L Clements","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Lou Clements","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028253446","display_name":"Geoffrey J. Gorse","orcid":"https://orcid.org/0000-0003-4558-2713","observed_orcids":["https://orcid.org/0000-0003-4558-2713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey J. Gorse","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002707102","display_name":"Peter F. Wright","orcid":"https://orcid.org/0000-0003-1950-6928","observed_orcids":["https://orcid.org/0000-0003-1950-6928"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter F. Wright","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074382084","display_name":"Thomas J. Matthews","orcid":"https://orcid.org/0000-0002-7624-244X","observed_orcids":["https://orcid.org/0000-0002-7624-244X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas J. Matthews","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000458556","display_name":"Gale Smith","orcid":"https://orcid.org/0000-0002-6482-6026","observed_orcids":["https://orcid.org/0000-0002-6482-6026"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gale E. Smith","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011603375","display_name":"Dale N. Lawrence","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dale Lawrence","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110272121","display_name":"Raphael Dolin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raphael Dolin","raw_affiliation_strings":[""],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4545,"has_fulltext":false,"cited_by_count":65,"citation_normalized_percentile":{"value":0.79256875,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"10","issue":"12","first_page":"1713","last_page":"1723"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-vaccine","display_name":"HIV-1 vaccine","score":0.8830000162124634},{"id":"https://openalex.org/keywords/vaccine-dose-comparison","display_name":"vaccine dose comparison","score":0.6679999828338623},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8399999737739563},{"id":"https://openalex.org/keywords/vaccine-safety","display_name":"vaccine safety","score":0.7379999756813049},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9419999718666077},{"id":"https://openalex.org/keywords/antibody-dependent-enhancement","display_name":"antibody-dependent enhancement","score":0.8539999723434448},{"id":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein","display_name":"HIV-1 envelope glycoprotein","score":0.6700000166893005},{"id":"https://openalex.org/keywords/lymphocyte-proliferative-response","display_name":"lymphocyte proliferative response","score":0.6850000023841858},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7076170444488525},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6473321914672852},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5875918865203857},{"id":"https://openalex.org/C2779909307","wikidata":"https://www.wikidata.org/wiki/Q1660181","display_name":"Immunogen","level":4,"score":0.5646054148674011},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.5410680770874023},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5103515982627869},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.47368577122688293},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4522966146469116},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37687885761260986},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.24388626217842102},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.08306121826171875},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004306","descriptor_name":"Dose-Response Relationship, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007110","descriptor_name":"Immunity, Active","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007111","descriptor_name":"Immunity, Cellular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007124","descriptor_name":"Immunoenzyme Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009500","descriptor_name":"Neutralization Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015686","descriptor_name":"Gene Products, env","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016915","descriptor_name":"AIDS Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018023","descriptor_name":"HIV Seronegativity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019302","descriptor_name":"HIV Envelope Protein gp160","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/aid.1994.10.1713","doi":"https://doi.org/10.1089/aid.1994.10.1713","is_oa":false,"landing_page_url":"https://doi.org/10.1089/aid.1994.10.1713","pdf_url":null,"source":{"id":"https://openalex.org/S161282271","display_name":"AIDS Research and Human Retroviruses","issn_l":"0889-2229","issn":["0889-2229","1931-8405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS Research and Human Retroviruses","raw_type":"journal-article"},{"id":"pmid:7888231","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7888231","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS research and human retroviruses","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G1063750474","display_name":"AIDS VACCINE EVALUATION UNIT","funder_award_id":"n01ai005064-007","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G280644093","display_name":"AIDS VACCINE EVALUATION UNIT","funder_award_id":"n01ai005063-000","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3603981032","display_name":null,"funder_award_id":"N01-AI-05062","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G641027377","display_name":"AIDS VACCINE EVALUATION UNIT","funder_award_id":"n01ai005062-000","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G8350234157","display_name":null,"funder_award_id":"N01-AI-05063","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G952203527","display_name":null,"funder_award_id":"N01AI05064","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W287737851","https://openalex.org/W1566499064","https://openalex.org/W1778074134","https://openalex.org/W1912026111","https://openalex.org/W1972959065","https://openalex.org/W1978406852","https://openalex.org/W1978875436","https://openalex.org/W1992657362","https://openalex.org/W2022290983","https://openalex.org/W2051589676","https://openalex.org/W2075674637","https://openalex.org/W2075924967","https://openalex.org/W2092985132","https://openalex.org/W2109210467","https://openalex.org/W2116372466","https://openalex.org/W2116557650","https://openalex.org/W2151290414","https://openalex.org/W2155131772","https://openalex.org/W2166853310","https://openalex.org/W2170908973","https://openalex.org/W2256756668","https://openalex.org/W2342332506","https://openalex.org/W4243272960","https://openalex.org/W4245957003"],"related_works":["https://openalex.org/W2116372466","https://openalex.org/W2155131772","https://openalex.org/W1982137744","https://openalex.org/W1972959065","https://openalex.org/W2022290983","https://openalex.org/W2051589676","https://openalex.org/W1966721356","https://openalex.org/W1555502539","https://openalex.org/W2063339038","https://openalex.org/W2033739895"],"abstract_inverted_index":{"We":[0],"examined":[1],"the":[2,121,144,152,169,243,250,273,283],"safety":[3],"and":[4,47,70,99,110,139,191],"immunogenicity":[5],"of":[6,23,97,102,105,108,126,178,188,194,201,220,227,239,256,272,276,294],"a":[7,34],"baculovirus-derived":[8],"recombinant":[9],"HIV-1":[10,131,171],"envelope":[11],"glycoprotein":[12],"vaccine":[13,279],"candidate,":[14],"rgp160":[15,278],"(VaxSyn;":[16],"MicroGeneSys,":[17],"Meriden,":[18],"CT),":[19],"administered":[20],"at":[21,43,300],"doses":[22,51,107,187,200,226,285],"160":[24,109,189],"or":[25,65,75,79],"640":[26,111,202,228],"micrograms":[27,203],"to":[28,86,130,151,161,163,249,282],"56":[29],"healthy,":[30],"HIV-1-seronegative":[31],"adults,":[32],"in":[33,95,100,120,136,143,176,192,218,235,242,254,268],"randomized,":[35],"double-blind,":[36],"placebo-controlled":[37],"study.":[38],"Immunizations":[39],"were":[40,52,60,68,81,89,133,155,159,174,252],"given":[41],"intramuscularly":[42],"0,":[44],"1,":[45],"6,":[46],"12":[48],"months.":[49],"Both":[50],"generally":[53],"well":[54],"tolerated,":[55],"although":[56,299],"self-limited":[57],"local":[58],"reactions":[59],"frequent.":[61],"No":[62],"other":[63],"clinical":[64],"laboratory":[66],"toxicities":[67],"noted,":[69],"no":[71,261],"effects":[72],"on":[73],"CD4":[74,213],"CD8":[76],"lymphocyte":[77],"counts":[78],"percentages":[80],"noted.":[82],"Serum":[83],"antibody":[84,128,149,209,297],"responses":[85,116,129,150,248],"HIV":[87],"proteins":[88],"detected":[90,253],"by":[91],"Western":[92,114],"blot":[93,115],"(WB)":[94],"19":[96,101,103,195,221,240],"20":[98,179],"recipients":[104],"four":[106,186,199,225],"micrograms,":[112,190],"respectively.":[113],"developed":[117,140],"more":[118,141],"rapidly":[119,142],"640-micrograms":[122,145,244,274],"group.":[123,146,245],"High":[124],"rates":[125,293],"EIA":[127],"lysate":[132],"also":[134,156],"present":[135],"both":[137],"groups,":[138],"Enzyme":[147],"immunoassay":[148],"immunogen":[153,251],"(rgp160)":[154],"frequent,":[157],"but":[158,260],"infrequent":[160],"V3":[162],"gp41":[164],"peptides.":[165],"Neutralizing":[166],"antibodies":[167],"against":[168],"homologous":[170,295],"LAI":[172],"isolate":[173],"seen":[175,217],"3":[177,219],"subjects":[180,196,222,258],"(GMT":[181,204],"=":[182,205],"11)":[183],"who":[184,197,223],"received":[185,198,224],"10":[193],"32).":[206],"Fusion":[207],"inhibiting":[208],"was":[210,216,233,266,286],"not":[211],"detected.":[212],"blocking":[214],"activity":[215,265],"micrograms.":[229],"Complement-mediated":[230],"antibody-dependent":[231],"enhancement":[232],"found":[234],"sera":[236],"from":[237],"11":[238,269],"volunteers":[241],"Lymphocyte":[246],"proliferative":[247],"4":[255,257],"tested,":[259],"cytotoxic":[262],"T":[263],"cell":[264],"noted":[267],"subjects.":[270],"Administration":[271],"dose":[275],"this":[277],"candidate":[280],"relative":[281],"lower":[284],"associated":[287],"with":[288],"increased":[289],"immunogenicity,":[290],"including":[291],"higher":[292],"neutralizing":[296],"responses,":[298],"low":[301],"titer.":[302]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2016-06-24T00:00:00"}